Senior insider sale
EVP, Chief Technology Officer at CVS HEALTH CORP — senior position signals high conviction
$6.23M
69.55K shares
What this filing means
MANDADI TILAK plans to sell 69.55K shares of CVS HEALTH CORP valued at approximately $6.23M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/8/2026ACC: 0001950047-26-004274
Officer· EVP, Chief Technology Officer
Since Jul 2022
69.55K
Shares to sell
$6.23M
Approx. market value
69.55K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Restricted Stock
Not Applicable
4/1/2026
2.48KRestricted Stock
Not Applicable
4/1/2026
3.12KRestricted Stock
Not Applicable
8/31/2025
20.45KRestricted Stock
Not Applicable
4/1/2025
3.09KRestricted Stock
Not Applicable
8/31/2024
20.18KRestricted Stock
Not Applicable
8/31/2023
20.23KTotal acquired69.55K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/1/2026 | Restricted Stock Not Applicable | 2.48K | — |
4/1/2026 | Restricted Stock Not Applicable | 3.12K | — |
8/31/2025 | Restricted Stock Not Applicable | 20.45K | — |
4/1/2025 | Restricted Stock Not Applicable | 3.09K | — |
8/31/2024 | Restricted Stock Not Applicable | 20.18K | — |
8/31/2023 | Restricted Stock Not Applicable | 20.23K | — |
| Total | 69.55K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
69.55K
Market value
$6.23M
5/8/2026
Total
Units
69.55K
Value
$6.23M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/8/2026 | 69.55K | $6.23M | NYSE | Planned |
| Total | 69.55K | $6.23M | ||